Literature DB >> 32747563

Optimizing immunization protocols to elicit broadly neutralizing antibodies.

Kayla G Sprenger1, Joy E Louveau2, Pranav M Murugan1, Arup K Chakraborty3,4,5,6,7.   

Abstract

Natural infections and vaccination with a pathogen typically stimulate the production of potent antibodies specific for the pathogen through a Darwinian evolutionary process known as affinity maturation. Such antibodies provide protection against reinfection by the same strain of a pathogen. A highly mutable virus, like HIV or influenza, evades recognition by these strain-specific antibodies via the emergence of new mutant strains. A vaccine that elicits antibodies that can bind to many diverse strains of the virus-known as broadly neutralizing antibodies (bnAbs)-could protect against highly mutable pathogens. Despite much work, the mechanisms by which bnAbs emerge remain uncertain. Using a computational model of affinity maturation, we studied a wide variety of vaccination strategies. Our results suggest that an effective strategy to maximize bnAb evolution is through a sequential immunization protocol, wherein each new immunization optimally increases the pressure on the immune system to target conserved antigenic sites, thus conferring breadth. We describe the mechanisms underlying why sequentially driving the immune system increasingly further from steady state, in an optimal fashion, is effective. The optimal protocol allows many evolving B cells to become bnAbs via diverse evolutionary paths.

Entities:  

Keywords:  broadly neutralizing antibodies; evolutionary biology; highly mutable pathogens; sequential vaccination; statistical mechanics

Mesh:

Substances:

Year:  2020        PMID: 32747563      PMCID: PMC7443869          DOI: 10.1073/pnas.1919329117

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  73 in total

Review 1.  Germinal center selection and the development of memory B and plasma cells.

Authors:  Mark J Shlomchik; Florian Weisel
Journal:  Immunol Rev       Date:  2012-05       Impact factor: 12.988

2.  Affinity maturation in an HIV broadly neutralizing B-cell lineage through reorientation of variable domains.

Authors:  Daniela Fera; Aaron G Schmidt; Barton F Haynes; Feng Gao; Hua-Xin Liao; Thomas B Kepler; Stephen C Harrison
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-30       Impact factor: 11.205

3.  Clonal selection in the germinal centre by regulated proliferation and hypermutation.

Authors:  Alexander D Gitlin; Ziv Shulman; Michel C Nussenzweig
Journal:  Nature       Date:  2014-05-04       Impact factor: 49.962

4.  Rational HIV immunogen design to target specific germline B cell receptors.

Authors:  Joseph Jardine; Jean-Philippe Julien; Sergey Menis; Takayuki Ota; Oleksandr Kalyuzhniy; Andrew McGuire; Devin Sok; Po-Ssu Huang; Skye MacPherson; Meaghan Jones; Travis Nieusma; John Mathison; David Baker; Andrew B Ward; Dennis R Burton; Leonidas Stamatatos; David Nemazee; Ian A Wilson; William R Schief
Journal:  Science       Date:  2013-03-28       Impact factor: 47.728

Review 5.  Germinal Center B Cell Dynamics.

Authors:  Luka Mesin; Jonatan Ersching; Gabriel D Victora
Journal:  Immunity       Date:  2016-09-20       Impact factor: 31.745

Review 6.  HIV-Host Interactions: Implications for Vaccine Design.

Authors:  Barton F Haynes; George M Shaw; Bette Korber; Garnett Kelsoe; Joseph Sodroski; Beatrice H Hahn; Persephone Borrow; Andrew J McMichael
Journal:  Cell Host Microbe       Date:  2016-02-25       Impact factor: 21.023

7.  Manipulating the selection forces during affinity maturation to generate cross-reactive HIV antibodies.

Authors:  Shenshen Wang; Jordi Mata-Fink; Barry Kriegsman; Melissa Hanson; Darrell J Irvine; Herman N Eisen; Dennis R Burton; K Dane Wittrup; Mehran Kardar; Arup K Chakraborty
Journal:  Cell       Date:  2015-02-05       Impact factor: 41.582

Review 8.  Antibodies in HIV-1 vaccine development and therapy.

Authors:  Florian Klein; Hugo Mouquet; Pia Dosenovic; Johannes F Scheid; Louise Scharf; Michel C Nussenzweig
Journal:  Science       Date:  2013-09-13       Impact factor: 47.728

9.  Host-Pathogen Coevolution and the Emergence of Broadly Neutralizing Antibodies in Chronic Infections.

Authors:  Armita Nourmohammad; Jakub Otwinowski; Joshua B Plotkin
Journal:  PLoS Genet       Date:  2016-07-21       Impact factor: 5.917

Review 10.  Adeno-associated virus gene delivery of broadly neutralizing antibodies as prevention and therapy against HIV-1.

Authors:  Allen Lin; Alejandro B Balazs
Journal:  Retrovirology       Date:  2018-10-01       Impact factor: 4.602

View more
  8 in total

1.  Determinants of anti-S immune response at 6 months after COVID-19 vaccination in a multicentric European cohort of healthcare workers - ORCHESTRA project.

Authors:  Giulia Collatuzzo; Giovanni Visci; Francesco S Violante; Stefano Porru; Gianluca Spiteri; Maria Grazia Lourdes Monaco; Francesca Larese Fillon; Corrado Negro; Christian Janke; Noemi Castelletti; Giuseppe De Palma; Emanuele Sansone; Dana Mates; Silvia Teodorescu; Eleonóra Fabiánová; Jana Bérešová; Luigi Vimercati; Silvio Tafuri; Mahsa Abedini; Giorgia Ditano; Shuffield S Asafo; Paolo Boffetta
Journal:  Front Immunol       Date:  2022-09-29       Impact factor: 8.786

2.  SARS-CoV-2 mRNA vaccine induces robust specific and cross-reactive IgG and unequal neutralizing antibodies in naive and previously infected people.

Authors:  Tara M Narowski; Kristin Raphel; Lily E Adams; Jenny Huang; Nadja A Vielot; Ramesh Jadi; Aravinda M de Silva; Ralph S Baric; John E Lafleur; Lakshmanane Premkumar
Journal:  Cell Rep       Date:  2022-01-20       Impact factor: 9.995

Review 3.  Protein engineering strategies for rational immunogen design.

Authors:  Timothy M Caradonna; Aaron G Schmidt
Journal:  NPJ Vaccines       Date:  2021-12-17       Impact factor: 7.344

4.  Multiscale affinity maturation simulations to elicit broadly neutralizing antibodies against HIV.

Authors:  Simone Conti; Victor Ovchinnikov; Jonathan G Faris; Arup K Chakraborty; Martin Karplus; Kayla G Sprenger
Journal:  PLoS Comput Biol       Date:  2022-04-20       Impact factor: 4.779

5.  Repeated exposure to heterologous hepatitis C viruses associates with enhanced neutralizing antibody breadth and potency.

Authors:  Nicole Frumento; Alexis Figueroa; Tingchang Wang; Muhammad N Zahid; Shuyi Wang; Guido Massaccesi; Georgia Stavrakis; James E Crowe; Andrew I Flyak; Hongkai Ji; Stuart C Ray; George M Shaw; Andrea L Cox; Justin R Bailey
Journal:  J Clin Invest       Date:  2022-08-01       Impact factor: 19.456

6.  Design of immunogens for eliciting antibody responses that may protect against SARS-CoV-2 variants.

Authors:  Eric Wang; Arup K Chakraborty
Journal:  PLoS Comput Biol       Date:  2022-09-26       Impact factor: 4.779

Review 7.  Phenotypes, Functions, and Clinical Relevance of Regulatory B Cells in Cancer.

Authors:  Jin Shang; Haoran Zha; Yufa Sun
Journal:  Front Immunol       Date:  2020-10-22       Impact factor: 7.561

8.  Predicting in vivo escape dynamics of HIV-1 from a broadly neutralizing antibody.

Authors:  Matthijs Meijers; Kanika Vanshylla; Henning Gruell; Florian Klein; Michael Lässig
Journal:  Proc Natl Acad Sci U S A       Date:  2021-07-27       Impact factor: 11.205

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.